330 related articles for article (PubMed ID: 32112905)
1. Hepatocellular carcinoma-derived exosomes in organotropic metastasis, recurrence and early diagnosis application.
Ge Y; Mu W; Ba Q; Li J; Jiang Y; Xia Q; Wang H
Cancer Lett; 2020 May; 477():41-48. PubMed ID: 32112905
[TBL] [Abstract][Full Text] [Related]
2. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).
Pan JH; Zhou H; Zhao XX; Ding H; Li W; Qin L; Pan YL
Int J Mol Med; 2018 Apr; 41(4):1809-1816. PubMed ID: 29328436
[TBL] [Abstract][Full Text] [Related]
3. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
[TBL] [Abstract][Full Text] [Related]
4. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.
Sun H; Wang C; Hu B; Gao X; Zou T; Luo Q; Chen M; Fu Y; Sheng Y; Zhang K; Zheng Y; Ren X; Yan S; Geng Y; Yang L; Dong Q; Qin L
Signal Transduct Target Ther; 2021 May; 6(1):187. PubMed ID: 34035222
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in the emerging role of exosome in hepatocellular carcinoma.
Abudoureyimu M; Zhou H; Zhi Y; Wang T; Feng B; Wang R; Chu X
Cell Prolif; 2019 Mar; 52(2):e12541. PubMed ID: 30397975
[TBL] [Abstract][Full Text] [Related]
6. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
[TBL] [Abstract][Full Text] [Related]
7. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value.
He R; Wang Z; Shi W; Yu L; Xia H; Huang Z; Liu S; Zhao X; Xu Y; Yam JWP; Cui Y
Biomed Pharmacother; 2021 Jun; 138():111529. PubMed ID: 34311529
[TBL] [Abstract][Full Text] [Related]
8. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.
Li C; Xu X
Cell Mol Life Sci; 2019 Nov; 76(21):4203-4219. PubMed ID: 31300868
[TBL] [Abstract][Full Text] [Related]
9. The significance of exosomes in the development and treatment of hepatocellular carcinoma.
Li X; Li C; Zhang L; Wu M; Cao K; Jiang F; Chen D; Li N; Li W
Mol Cancer; 2020 Jan; 19(1):1. PubMed ID: 31901224
[TBL] [Abstract][Full Text] [Related]
10. The functional role of exosome in hepatocellular carcinoma.
Liu H; Li B
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2085-2095. PubMed ID: 30062486
[TBL] [Abstract][Full Text] [Related]
11. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
Wu Q; Zhou L; Lv D; Zhu X; Tang H
J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses.
Li S; Yao J; Xie M; Liu Y; Zheng M
J Hematol Oncol; 2018 Apr; 11(1):54. PubMed ID: 29642941
[TBL] [Abstract][Full Text] [Related]
14. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs.
He M; Qin H; Poon TC; Sze SC; Ding X; Co NN; Ngai SM; Chan TF; Wong N
Carcinogenesis; 2015 Sep; 36(9):1008-18. PubMed ID: 26054723
[TBL] [Abstract][Full Text] [Related]
16. RAB5A effect on metastasis of hepatocellular carcinoma cell line via altering the pro-invasive content of exosomes.
Gorji-Bahri G; Moghimi HR; Hashemi A
Exp Mol Pathol; 2021 Jun; 120():104632. PubMed ID: 33831402
[TBL] [Abstract][Full Text] [Related]
17. Exosomes: small vesicles with big roles in hepatocellular carcinoma.
Wu Z; Zeng Q; Cao K; Sun Y
Oncotarget; 2016 Sep; 7(37):60687-60697. PubMed ID: 27463001
[TBL] [Abstract][Full Text] [Related]
18. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
[TBL] [Abstract][Full Text] [Related]
19. CD81
Ashraf Malik M; Ishtiyaq Ali Mirza J; Umar M; Manzoor S
Viral Immunol; 2019 Dec; 32(10):453-462. PubMed ID: 31755827
[TBL] [Abstract][Full Text] [Related]
20. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]